Lipid exchange of apolipoprotein A‐I amyloidogenic variants in reconstituted high‐density lipoprotein with artificial membranes

Author:

Correa Yubexi1,Ravel Mathilde1,Imbert Marie1,Waldie Sarah1,Clifton Luke2,Terry Ann3,Roosen‐Runge Felix1,Lagerstedt Jens O.45ORCID,Moir Michael6,Darwish Tamim67,Cárdenas Marité189ORCID,Del Giudice Rita1ORCID

Affiliation:

1. Biofilm – Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society Malmö University Malmö Sweden

2. ISIS Pulsed Neutron and Muon Source, Science and Technology Facilities Council Rutherford Appleton Laboratory, Harwell Science and Innovation Campus Didcot UK

3. MAX IV Laboratory CoSAXS Beamline, Lund University Lund Sweden

4. Islet Cell Exocytosis, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre Lund University Malmö Sweden

5. Rare Endocrine Disorders, Research and Early Development Novo Nordisk Copenhagen Denmark

6. National Deuteration Facility Australian Nuclear Science and Technology Organization (ANSTO) Lucas Heights New South Wales Australia

7. Faculty of Science and Technology University of Canberra Canberra Australian Capital Territory Australia

8. Ikerbasque, Basque Foundation for Science Bilbao Spain

9. Biofisika Institute (University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC)) Leioa Spain

Abstract

AbstractHigh‐density lipoproteins (HDLs) are responsible for removing cholesterol from arterial walls, through a process known as reverse cholesterol transport. The main protein in HDL, apolipoprotein A‐I (ApoA‐I), is essential to this process, and changes in its sequence significantly alter HDL structure and functions. ApoA‐I amyloidogenic variants, associated with a particular hereditary degenerative disease, are particularly effective at facilitating cholesterol removal, thus protecting carriers from cardiovascular disease. Thus, it is conceivable that reconstituted HDL (rHDL) formulations containing ApoA‐I proteins with functional/structural features similar to those of amyloidogenic variants hold potential as a promising therapeutic approach. Here we explored the effect of protein cargo and lipid composition on the function of rHDL containing one of the ApoA‐I amyloidogenic variants G26R or L174S by Fourier transformed infrared spectroscopy and neutron reflectometry. Moreover, small‐angle x‐ray scattering uncovered the structural and functional differences between rHDL particles, which could help to comprehend higher cholesterol efflux activity and apparent lower phospholipid (PL) affinity. Our findings indicate distinct trends in lipid exchange (removal vs. deposition) capacities of various rHDL particles, with the rHDL containing the ApoA‐I amyloidogenic variants showing a markedly lower ability to remove lipids from artificial membranes compared to the rHDL containing the native protein. This effect strongly depends on the level of PL unsaturation and on the particles' ultrastructure. The study highlights the importance of the protein cargo, along with lipid composition, in shaping rHDL structure, contributing to our understanding of lipid–protein interactions and their behavior.

Funder

Vetenskapsrådet

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3